Neogen Corporation (NEOG)
USD 11.64
(-4.04%)
USD 11.64
(-4.04%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 735.62 Million USD | -0.15% |
| 2023 | 736.76 Million USD | 21.65% |
| 2022 | 605.63 Million USD | 259.46% |
| 2021 | -379.8 Million USD | -10.85% |
| 2020 | -342.61 Million USD | -28.07% |
| 2019 | -267.52 Million USD | -26.9% |
| 2018 | -210.81 Million USD | -46.77% |
| 2017 | -143.63 Million USD | -33.25% |
| 2016 | -107.79 Million USD | 5.58% |
| 2015 | -114.16 Million USD | -49.24% |
| 2014 | -76.49 Million USD | 10.39% |
| 2013 | -85.36 Million USD | -24.36% |
| 2012 | -68.64 Million USD | -91.51% |
| 2011 | -35.84 Million USD | -57.17% |
| 2010 | -22.8 Million USD | -64.76% |
| 2009 | -13.84 Million USD | 3.0% |
| 2008 | -14.27 Million USD | -6.3% |
| 2007 | -13.42 Million USD | -264.79% |
| 2006 | 8.14 Million USD | 513.08% |
| 2005 | -1.97 Million USD | -177.79% |
| 2004 | 2.53 Million USD | 338.93% |
| 2003 | -1.06 Million USD | 47.27% |
| 2002 | -2.01 Million USD | -160.96% |
| 2001 | -771 Thousand USD | 52.47% |
| 2000 | -1.62 Million USD | -62.2% |
| 1999 | -1 Million USD | -100.0% |
| 1998 | -500 Thousand USD | -25.0% |
| 1997 | -400 Thousand USD | 50.0% |
| 1996 | -800 Thousand USD | -33.33% |
| 1995 | -600 Thousand USD | -50.0% |
| 1994 | -400 Thousand USD | -100.0% |
| 1993 | -200 Thousand USD | -300.0% |
| 1992 | 100 Thousand USD | 103.03% |
| 1991 | -3.3 Million USD | 0.0% |
| 1990 | -3.3 Million USD | -320.0% |
| 1989 | 1.5 Million USD | 7.14% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 683.71 Million USD | -3.7% |
| 2024 FY | 735.62 Million USD | -0.15% |
| 2024 Q4 | 735.62 Million USD | 0.95% |
| 2024 Q3 | 728.73 Million USD | 6.58% |
| 2024 Q1 | 709.98 Million USD | -1.69% |
| 2023 FY | 736.76 Million USD | 21.65% |
| 2023 Q3 | 817.56 Million USD | 26.24% |
| 2023 Q2 | 647.62 Million USD | 286.25% |
| 2023 Q1 | -347.71 Million USD | -157.41% |
| 2023 Q4 | 722.19 Million USD | -11.66% |
| 2022 Q3 | -375.65 Million USD | 2.95% |
| 2022 FY | 605.63 Million USD | 259.46% |
| 2022 Q4 | 605.63 Million USD | 261.22% |
| 2022 Q2 | -387.06 Million USD | 2.86% |
| 2022 Q1 | -398.47 Million USD | -4.92% |
| 2021 Q3 | -352.25 Million USD | 9.61% |
| 2021 Q2 | -389.7 Million USD | -6.33% |
| 2021 FY | -379.8 Million USD | -10.85% |
| 2021 Q1 | -366.52 Million USD | -6.93% |
| 2021 Q4 | -379.8 Million USD | -7.82% |
| 2020 FY | -342.61 Million USD | -28.07% |
| 2020 Q2 | -312.14 Million USD | -464.39% |
| 2020 Q3 | -326.45 Million USD | -4.58% |
| 2020 Q4 | -342.76 Million USD | -4.99% |
| 2020 Q1 | -55.3 Million USD | 79.33% |
| 2019 Q4 | -267.52 Million USD | -8.45% |
| 2019 Q2 | -240.97 Million USD | -6.43% |
| 2019 Q1 | -226.41 Million USD | -7.4% |
| 2019 FY | -267.52 Million USD | -26.9% |
| 2019 Q3 | -246.68 Million USD | -2.37% |
| 2018 Q3 | -175.78 Million USD | -14.59% |
| 2018 Q4 | -210.81 Million USD | -19.93% |
| 2018 FY | -210.81 Million USD | -46.77% |
| 2018 Q1 | -159.99 Million USD | -11.39% |
| 2018 Q2 | -153.39 Million USD | 4.12% |
| 2017 Q3 | -124.58 Million USD | -0.93% |
| 2017 Q1 | -129.22 Million USD | -19.88% |
| 2017 FY | -143.63 Million USD | -33.25% |
| 2017 Q2 | -123.43 Million USD | 4.48% |
| 2017 Q4 | -143.63 Million USD | -15.29% |
| 2016 Q2 | -123.01 Million USD | -10.87% |
| 2016 Q1 | -110.95 Million USD | 2.81% |
| 2016 FY | -107.79 Million USD | 5.58% |
| 2016 Q4 | -107.79 Million USD | 13.87% |
| 2016 Q3 | -125.15 Million USD | -1.74% |
| 2015 Q4 | -114.16 Million USD | -98.6% |
| 2015 Q2 | -94.3 Million USD | -7.05% |
| 2015 Q1 | -88.09 Million USD | -15.17% |
| 2015 Q3 | -57.48 Million USD | 39.04% |
| 2015 FY | -114.16 Million USD | -49.24% |
| 2014 Q3 | -68.81 Million USD | 13.0% |
| 2014 Q1 | -84.37 Million USD | 1.16% |
| 2014 FY | -76.49 Million USD | 10.39% |
| 2014 Q2 | -79.09 Million USD | 6.26% |
| 2014 Q4 | -76.49 Million USD | -11.17% |
| 2013 Q3 | -74.56 Million USD | -5.26% |
| 2013 Q4 | -85.36 Million USD | -14.49% |
| 2013 Q2 | -70.83 Million USD | 4.92% |
| 2013 Q1 | -74.5 Million USD | -8.54% |
| 2013 FY | -85.36 Million USD | -24.36% |
| 2012 Q3 | -42.69 Million USD | -15.49% |
| 2012 Q1 | -22.03 Million USD | 38.53% |
| 2012 Q4 | -68.64 Million USD | -60.77% |
| 2012 FY | -68.64 Million USD | -91.51% |
| 2012 Q2 | -36.97 Million USD | -67.81% |
| 2011 FY | -35.84 Million USD | -57.17% |
| 2011 Q4 | -35.84 Million USD | 24.74% |
| 2011 Q3 | -47.62 Million USD | -7.29% |
| 2011 Q2 | -44.39 Million USD | -31.72% |
| 2011 Q1 | -33.7 Million USD | -47.77% |
| 2010 FY | -22.8 Million USD | -64.76% |
| 2010 Q1 | -23.56 Million USD | -70.24% |
| 2010 Q2 | -32.45 Million USD | -37.73% |
| 2010 Q3 | -31.1 Million USD | 4.15% |
| 2010 Q4 | -22.8 Million USD | 26.69% |
| 2009 Q4 | -13.84 Million USD | -0.81% |
| 2009 FY | -13.84 Million USD | 3.0% |
| 2009 Q1 | -9.65 Million USD | 32.35% |
| 2009 Q3 | -13.73 Million USD | -7.94% |
| 2009 Q2 | -12.72 Million USD | -31.77% |
| 2008 Q4 | -14.27 Million USD | -28.64% |
| 2008 Q2 | -10.41 Million USD | -53.48% |
| 2008 Q1 | -6.78 Million USD | 49.45% |
| 2008 FY | -14.27 Million USD | -6.3% |
| 2008 Q3 | -11.09 Million USD | -6.51% |
| 2007 FY | -13.42 Million USD | -264.79% |
| 2007 Q1 | -3.31 Million USD | -140.69% |
| 2007 Q4 | -13.42 Million USD | -431.85% |
| 2007 Q2 | -3.28 Million USD | 1.03% |
| 2007 Q3 | -2.52 Million USD | 23.07% |
| 2006 Q3 | 10.92 Million USD | 473.33% |
| 2006 FY | 8.14 Million USD | 513.08% |
| 2006 Q4 | 8.14 Million USD | -25.4% |
| 2006 Q2 | -2.92 Million USD | -14.71% |
| 2006 Q1 | -2.55 Million USD | -29.31% |
| 2005 Q1 | 846 Thousand USD | -66.63% |
| 2005 Q2 | 1.04 Million USD | 23.29% |
| 2005 Q3 | 1.01 Million USD | -2.4% |
| 2005 Q4 | -1.97 Million USD | -293.71% |
| 2005 FY | -1.97 Million USD | -177.79% |
| 2004 Q4 | 2.53 Million USD | -15.58% |
| 2004 FY | 2.53 Million USD | 338.93% |
| 2004 Q3 | 3 Million USD | 120.65% |
| 2004 Q2 | 1.36 Million USD | 352.04% |
| 2004 Q1 | -540 Thousand USD | 49.1% |
| 2003 Q4 | -1.06 Million USD | 63.19% |
| 2003 FY | -1.06 Million USD | 47.27% |
| 2003 Q3 | -2.88 Million USD | -151.48% |
| 2003 Q2 | -1.14 Million USD | 29.48% |
| 2003 Q1 | -1.62 Million USD | 19.23% |
| 2002 Q1 | -634 Thousand USD | 17.77% |
| 2002 FY | -2.01 Million USD | -160.96% |
| 2002 Q2 | -449 Thousand USD | 29.18% |
| 2002 Q3 | -1.04 Million USD | -131.85% |
| 2002 Q4 | -2.01 Million USD | -93.28% |
| 2001 Q1 | -1.05 Million USD | 34.9% |
| 2001 Q4 | -771 Thousand USD | -73.65% |
| 2001 Q3 | -444 Thousand USD | 44.98% |
| 2001 Q2 | -807 Thousand USD | 23.58% |
| 2001 FY | -771 Thousand USD | 52.47% |
| 2000 Q1 | -1 Million USD | 0.0% |
| 2000 Q4 | -1.62 Million USD | -83.48% |
| 2000 FY | -1.62 Million USD | -62.2% |
| 2000 Q3 | -884 Thousand USD | -47.33% |
| 2000 Q2 | -600 Thousand USD | 40.0% |
| 1999 FY | -1 Million USD | -100.0% |
| 1999 Q4 | -1 Million USD | 9.09% |
| 1999 Q3 | -1.1 Million USD | -57.14% |
| 1999 Q2 | -700 Thousand USD | 0.0% |
| 1999 Q1 | -700 Thousand USD | -40.0% |
| 1998 Q1 | -900 Thousand USD | -125.0% |
| 1998 Q4 | -500 Thousand USD | 16.67% |
| 1998 Q3 | -600 Thousand USD | -100.0% |
| 1998 Q2 | -300 Thousand USD | 66.67% |
| 1998 FY | -500 Thousand USD | -25.0% |
| 1997 Q1 | -1 Million USD | -25.0% |
| 1997 Q4 | -400 Thousand USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 100.0% |
| 1997 FY | -400 Thousand USD | 50.0% |
| 1996 Q3 | -400 Thousand USD | -300.0% |
| 1996 Q4 | -800 Thousand USD | -100.0% |
| 1996 Q2 | 200 Thousand USD | 0.0% |
| 1996 FY | -800 Thousand USD | -33.33% |
| 1996 Q1 | 200 Thousand USD | 133.33% |
| 1995 Q4 | -600 Thousand USD | 0.0% |
| 1995 FY | -600 Thousand USD | -50.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 FY | -400 Thousand USD | -100.0% |
| 1994 Q4 | -400 Thousand USD | 0.0% |
| 1994 Q1 | - USD | 100.0% |
| 1993 Q1 | -1.1 Million USD | -1200.0% |
| 1993 FY | -200 Thousand USD | -300.0% |
| 1993 Q4 | -200 Thousand USD | 0.0% |
| 1992 Q4 | 100 Thousand USD | 0.0% |
| 1992 FY | 100 Thousand USD | 103.03% |
| 1991 FY | -3.3 Million USD | 0.0% |
| 1991 Q4 | -3.3 Million USD | 0.0% |
| 1990 Q4 | -3.3 Million USD | 0.0% |
| 1990 FY | -3.3 Million USD | -320.0% |
| 1989 FY | 1.5 Million USD | 7.14% |
| 1989 Q4 | 1.5 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bionano Genomics, Inc. | 34.88 Million USD | -2008.904% |
| Prenetics Global Limited | -43.33 Million USD | 1797.457% |
| Star Equity Holdings, Inc. | -15.33 Million USD | 4896.427% |
| CareDx, Inc | -47.97 Million USD | 1633.325% |
| Exact Sciences Corporation | 1.94 Billion USD | 62.263% |
| Exagen Inc. | -12.77 Million USD | 5859.693% |
| Inotiv, Inc. | 382.14 Million USD | -92.498% |
| Guardant Health, Inc. | 220.22 Million USD | -234.032% |
| Biodesix, Inc. | 34.3 Million USD | -2044.25% |
| BioNexus Gene Lab Corp. | -5.79 Million USD | 12792.124% |
| Precipio, Inc. | -386 Thousand USD | 190677.202% |
| iSpecimen Inc. | -2.14 Million USD | 34356.332% |
| Natera, Inc. | -200.1 Million USD | 467.627% |
| Aspira Women's Health Inc. | -331 Thousand USD | 222344.109% |
| Standard BioTools Inc. | 46.5 Million USD | -1481.792% |
| 23andMe Holding Co. | -141.37 Million USD | 620.349% |
| Castle Biosciences, Inc. | -83.53 Million USD | 980.665% |
| Personalis, Inc. | -8.02 Million USD | 9270.132% |
| Aclaris Therapeutics, Inc. | -39.45 Million USD | 1964.615% |
| Applied DNA Sciences, Inc. | -5.91 Million USD | 12538.671% |
| OpGen, Inc. | 11.89 Million USD | -6085.967% |
| T2 Biosystems, Inc. | 33.8 Million USD | -2075.835% |
| Myriad Genetics, Inc. | 88.1 Million USD | -734.992% |
| ICON Public Limited Company | 3.56 Billion USD | 79.338% |
| NeoGenomics, Inc. | 269.19 Million USD | -173.274% |
| Star Equity Holdings, Inc. | -15.33 Million USD | 4896.427% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -48.928% |
| RadNet, Inc. | 1.14 Billion USD | 35.952% |
| MDxHealth SA | 18.88 Million USD | -3795.303% |
| Psychemedics Corporation | 334 Thousand USD | -220147.904% |
| Illumina, Inc. | 1.21 Billion USD | 39.405% |
| Check-Cap Ltd. | -24.75 Million USD | 3071.514% |
| Twist Bioscience Corporation | -192.4 Million USD | 482.341% |
| DarioHealth Corp. | -7.54 Million USD | 9845.999% |
| Fulgent Genetics, Inc. | -82.56 Million USD | 990.958% |
| Sera Prognostics, Inc. | -2.02 Million USD | 36481.207% |
| ENDRA Life Sciences Inc. | -2.43 Million USD | 30254.818% |
| OPKO Health, Inc. | 230.68 Million USD | -218.891% |
| Medpace Holdings, Inc. | -103.32 Million USD | 811.942% |
| Intelligent Bio Solutions Inc. | -5.43 Million USD | 13640.849% |
| Prenetics Global Limited | -43.33 Million USD | 1797.457% |
| Mainz Biomed B.V. | 349.85 Thousand USD | -210166.539% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | 59284.943% |
| Trinity Biotech plc | 63.73 Million USD | -1054.18% |
| Neuronetics, Inc. | 2.79 Million USD | -26200.608% |
| Sotera Health Company | 2.02 Billion USD | 63.68% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | 59284.943% |